MEDP today
$664.77+$0.23 (+0.03%)close Nov 11, 2026Trend
DailyUptrend (confirmed)
4 hourBullish
1 hourAscending Triangle
15 minBearish
5 minConsolidating
Daily trend turns down below $563.45
Key levels
Resistance$679.18
Support$640.00
Support$590.46
Latest news & SEC filings
SEC FilingMedpace Holdings, Inc. filed an insider trading report (Form 4)
AnalystBMO Capital keeps Market Perform on Medpace, lifts target to $670
All MEDP news →About Medpace
Medpace is a contract research organization that runs clinical trials on behalf of drug, biologic, and device makers. It handles studies from early-stage through post-approval work, covering areas such as trial management, patient enrollment, monitoring, regulatory filings, data analysis, safety reporting, and lab testing. Its clients range from smaller biotech firms to large pharmaceutical companies. It operates worldwide, with laboratory sites in North America, Europe, and Asia.
Based on the company's 10-K filed Feb 10, 2026.
Nasdaq · Healthcare
Medpace Holdings, Inc. (MEDP)
What Is the Price Target for MEDP?
SEPT Low Target
$531.25
SEPT Mid Target
$625.00
SEPT High Target
$718.75
Analyst Consensus
$625.00
Is MEDP a Buy or Sell Right Now?
Thesis
- •Revenue growing 20.0% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MEDP.
Start Free Trial →Is MEDP Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$505.16
48
Moat Score
NARROW
6/9
Piotroski Score
8.9
Altman Z-Score
What Is Smart Money Doing with MEDP?
Insider Signal
SELLING
0 buys / 16 sells (90d)
Congress Signal
BUYING
3 buys / 2 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| BURWIG SUSAN E | officer | Sale | 3,940 | $2.7M | Oct 27, 2026 |
| BURWIG SUSAN E | officer | Sale | 16,060 | $10.9M | Oct 26, 2026 |
| BURWIG SUSAN E | officer | Buy | 328 | $55K | Oct 26, 2026 |
| BURWIG SUSAN E | officer | Buy | 2,700 | $450K | Oct 21, 2026 |
| BURWIG SUSAN E | officer | Buy | 3,000 | $500K | Oct 12, 2026 |
| BURWIG SUSAN E | officer | Buy | 2,000 | $333K | Oct 7, 2026 |
| Troendle August J. | director officer 10% owner | Sale | 21,966 | $13.7M | Sep 30, 2026 |
| Kraft Robert O. | director | Buy | 32 | - | Sep 30, 2026 |
| Troendle August J. | director officer 10% owner | Sale | 26,701 | $16.6M | Sep 29, 2026 |
| Troendle August J. | director officer 10% owner | Sale | 2,410 | $1.5M | Sep 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MEDP Growth Story
Revenue YoY
20.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
20.98%
FCF Growth YoY
19.1%
Revenue Trend
ACCELERATING
Dark Pool Trades for MEDP
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MEDP, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:54:48 | $665.22 | 2,147 | $$1.4M | SELL |
| 15:52:55 | $663.47 | 1,699 | $$1.1M | SELL |
| 15:10:50 | $664.90 | 1,882 | $$1.3M | BUY |
| 15:08:13 | $664.43 | 1,100 | $$731K | SELL |
| 15:04:15 | $668.34 | 1,377 | $$920K | BUY |
5 dark pool trades shown · $$5.5M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Medpace Holdings, Inc. (MEDP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MEDP — frequently asked questions
What is MEDP stock price today?
Medpace Holdings, Inc. (MEDP) is at $664.77, up 0.03% (+$0.23) at the Nov 11, 2026 close.
Why is MEDP stock moving today?
Latest MEDP news — Nov 2, 2026: Medpace Holdings, Inc. filed an insider trading report (Form 4) · Oct 26, 2026: BMO Capital keeps Market Perform on Medpace, lifts target to $670
What is the MEDP price target?
The average analyst price target for MEDP is $625.00, ranging from $600 to $700, based on 7 analysts. Latest: Barclays maintains on Oct 7, 2026.
What do analysts rate MEDP?
Analyst ratings for MEDP: 1 Buy, 11 Hold, 2 Sell — consensus Hold.
Did MEDP beat earnings?
MEDP last reported on Oct 21, 2026: EPS $4.84 vs $4.44 expected — a beat of 9.0%.
What is MEDP's P/E ratio?
MEDP trades at a P/E of 40.7.
Does MEDP pay a dividend?
MEDP does not currently pay a dividend.
What are MEDP support and resistance levels?
Support: $640.00, $590.46, $563.45. Resistance: $679.18.
What are insiders doing with MEDP?
Insider activity: SELLING, 0 buys and 16 sells in the last 90 days.
What is the latest news on MEDP?
Nov 2, 2026: Medpace Holdings, Inc. filed an insider trading report (Form 4) · Oct 26, 2026: BMO Capital keeps Market Perform on Medpace, lifts target to $670